Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J gets first-of-its-kind prostate cancer approval
J&J gets first-of-its-kind prostate cancer approval
J&J gets first-of-its-kind prostate cancer approval
Submitted by
admin
on February 14, 2018 - 11:48pm
Source:
Biopharma Dive
News Tags:
JNJ
apalutamide
prostate cancer
Headline:
J&J gets first-of-its-kind prostate cancer approval
Do Not Allow Advertisers to Use My Personal information